Anterogen Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 42
Employees
  • Stock Symbol
  • 065660
Stock Symbol
  • Share Price
  • $54.81
  • (As of Friday Closing)

Anterogen General Information

Description

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • Namsung Plaza, Gasan-dong, 405, 130, Digital-ro
  • Geumcheon-gu
  • Seoul, 08589
  • South Korea
+82 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anterogen Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$54.81 $56.53 $19.41 - $73.00 $491M 8.96M 170K -$0.64

Anterogen Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 366,005 284,514 519,095 319,928
Revenue 3,496 3,557 3,282 4,724
EBITDA (4,433) (2,796) 538 501
Net Income (5,612) (3,473) (875) 394
Total Assets 82,227 73,030 90,710 54,404
Total Debt 7,597 7,206 26,372 8,723
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anterogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anterogen‘s full profile, request access.

Request a free trial

Anterogen Executive Team (2)

Name Title Board Seat Contact Info
Lee Seong-gu Chief Executive Officer
Ike Wan Lee Ph.D Chief Scientific Officer & Founder
To view Anterogen’s complete executive team members history, request access »

Anterogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial